Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
3.680
-0.050 (-1.34%)
Sep 3, 2025, 2:45 PM CST
SHA:600664 Market Cap
SHA:600664 has a market cap or net worth of 9.27 billion as of September 3, 2025. Its market cap has increased by 12.20% in one year.
Market Cap
9.27B
Enterprise Value
8.27B
Revenue
16.16B
Ranking
n/a
PE Ratio
17.47
Stock Price
3.68
Market Cap Chart
Since August 28, 2006, SHA:600664's market cap has increased from 7.45B to 9.27B, an increase of 24.37%. That is a compound annual growth rate of 1.15%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 2, 2025 | 9.39B | -9.69% |
Dec 31, 2024 | 10.40B | 23.17% |
Dec 29, 2023 | 8.45B | 11.14% |
Dec 30, 2022 | 7.60B | -15.00% |
Dec 31, 2021 | 8.94B | 11.79% |
Dec 31, 2020 | 8.00B | -15.83% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 440.21B |
WuXi AppTec | 300.63B |
Shenzhen Mindray Bio-Medical Electronics | 293.63B |
Sichuan Biokin Pharmaceutical | 134.13B |
Zhangzhou Pientzehuang Pharmaceutical., | 126.23B |
Aier Eye Hospital Group | 124.56B |
Shanghai United Imaging Healthcare | 116.28B |
Yunnan Baiyao Group Co.,Ltd | 102.74B |